| The margination propensity of ellipsoidal micro/nanoparticles to the endothelium in human blood flow AJ Thompson, EM Mastria, O Eniola-Adefeso Biomaterials 34 (23), 5863-5871, 2013 | 134 | 2013 |
| One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer KM Luginbuhl, JL Schaal, B Umstead, EM Mastria, X Li, S Banskota, ... Nature biomedical engineering 1 (6), 0078, 2017 | 111 | 2017 |
| Fabrication of biodegradable spheroidal microparticles for drug delivery applications MJ Heslinga, EM Mastria, O Eniola-Adefeso Journal of Controlled Release 138 (3), 235-242, 2009 | 85 | 2009 |
| Injectable polypeptide micelles that form radiation crosslinked hydrogels in situ for intratumoral radiotherapy JL Schaal, X Li, E Mastria, J Bhattacharyya, MR Zalutsky, A Chilkoti, W Liu Journal of Controlled Release 228, 58-66, 2016 | 79 | 2016 |
| Doxorubicin-conjugated polypeptide nanoparticles inhibit metastasis in two murine models of carcinoma EM Mastria, M Chen, JR McDaniel, X Li, J Hyun, MW Dewhirst, A Chilkoti Journal of controlled release 208, 52-58, 2015 | 65 | 2015 |
| Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity EM Mastria, LY Cai, MJ Kan, X Li, JL Schaal, S Fiering, MD Gunn, ... Journal of Controlled Release 269, 364-373, 2018 | 59 | 2018 |
| A quantitative study of the intracellular fate of pH-responsive doxorubicin-polypeptide nanoparticles J Wang, J Bhattacharyya, E Mastria, A Chilkoti Journal of Controlled Release 260, 100-110, 2017 | 37 | 2017 |
| Intratumoral delivery of brachytherapy and immunotherapy by a thermally triggered polypeptide depot G Kelly, JJ Milligan, EM Mastria, S Kim, SR Zelenetz, J Dobbins, LY Cai, ... Journal of Controlled Release 343, 267-276, 2022 | 16 | 2022 |
| Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in Pten-deleted Mouse Models of Sarcoma RD Dodd, A Scherer, W Huang, GR McGivney, WR Gutierrez, EA Laverty, ... Clinical cancer research 26 (18), 5036-5047, 2020 | 7 | 2020 |
| Genetically encoded “smart” peptide polymers for biomedicine E Mastria, A Chilkoti MRS bulletin 39 (1), 35-43, 2014 | 5 | 2014 |
| D. D′ Alessio, A. Chilkoti, Nat KM Luginbuhl, JL Schaal, B Umstead, EM Mastria, X Li, S Banskota, ... Biomed. Eng 1, 1-14, 2017 | 4 | 2017 |
| Next-generation brachytherapy: a preclinical study of a thermally stabilized biopolymer gel for delivering intratumoral radionuclide therapy in a pancreatic tumor mouse model JL Schaal, W Liu, A Chilkoti, X Li, E Mastria, MR Zalutsky Cancer Research 75 (15_Supplement), 1809-1809, 2015 | 1 | 2015 |
| Radioembolization in the Treatment of Primary Liver Cancer EM Mastria, RP Lokken, ED Lehrman Interventional Oncology: A Multidisciplinary Approach to Image-Guided Cancer …, 2023 | | 2023 |
| Evaluating Radioactive Analogs of Doxorubicin to Quantify ChemoFilter Binding and Whole-Body Positron Emission Tomography/Magnetic Resonance Imaging for Drug Biodistribution P Kumar, C Yee, JE Blecha, TR Hayes, BF Kilbride, C Stillson, AD Losey, ... Journal of Vascular and Interventional Radiology 33 (6), 687-694, 2022 | | 2022 |
| Improving Anticancer Therapy with ELP-based Drug Delivery Systems EM Mastria Duke University, 2016 | | 2016 |
| Whole Body PET/MRI Biodistribution of F-18 fluorobenzylamide doxorubicin in an Intra-arterial Procedure P Kumar, CD Jordan, JE Blecha, TR Hayes, C Stillson, AD Losey, ... | | |
Ashutosh ChilkotiDuke UniversityVerified email at duke.edu
